Open AccessAdjuvant Chemotherapy in Resected Lung Cancer: Two-Year Experience in a University Hospital
Author(s) -
Nicole Bouchard,
Francis Laberge,
Bruno Raby,
Sylvie Martin,
Yves Lacasse
Publication year - 2008
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2008/462147
Subject(s) - medicine , vinorelbine , carboplatin , lung cancer , chemotherapy , surgery , etoposide , stage (stratigraphy) , oncology , cisplatin , paleontology , biology
Randomized trials have confirmed the benefits of adjuvant chemotherapy in improving survival in resected early-stage non-small-cell lung cancer (NSCLC). The extent to which these results have translated into clinical practice is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom